Urolog. pro Praxi, 2006; 5: 214-218

IS PSA TEST A USEFUL TOOL FOR DETECTING PROSTATE CANCER?

doc. MUDr. Vladimír Študent Ph.D, MUDr. Michal Grepl, MUDr. Milan Král, MUDr. Igor Hartmann
Urologická klinika FN a LF UP v Olomouci

Carcinoma of the prostate (CaP) is a very serious disease in men over the age of 50 years with a high prevalence among men in the Czech Republic. Up to now however no standardized screening has been carried out to this condition. One of the possibilities for detecting early stages of CaP is PSA (prostate specific antigen) examination. It is necessary to use age specific PSA and use the ratio FPSA/PSA, kinetic of PSA, that means PSA-V eventually PSA-DT

Keywords: Key words: carcinoma of the prostate, PSA, general practitioner.

Published: January 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Študent V, Grepl M, Král M, Hartmann I. IS PSA TEST A USEFUL TOOL FOR DETECTING PROSTATE CANCER? Urol. praxi. 2006;7(5):214-218.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. http://www.cba.muni.cz/svod/.
    2. Thomson IM et al. Prevalence of prostate cancer among men with prostatic specific antigen level < 4,0 ng per mililiter. N Engl J Med 2004; 27, 350(22): 2239-2246. Go to original source... Go to PubMed...
    3. Loeb S et al. Baseline PSA compared with median PSA for age group as predictor of pathologic tumor features in men < 60 years of age. AUA, San Antonio 2005: Abstract 533. Go to original source...
    4. D'Amico AV, Chen MH, Roehl KA, Catalona WJ. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 2004; 8, 351(2): 125-135. Go to original source... Go to PubMed...
    5. Hornirger W MD et al. Screening for prostate cancer: updated experience from the Tyrol study. Can J Urol 2005; 12 (Suppl 1): 7-13, 92-93.
    6. http://www.nccn.org/professionals/physician_gls/PDF/prostate.pdf.
    7. Catalona WJ, Loeb S. The PSA era is not over for prostate cancer. Eur Urol 2005; 48 (4): 541-545. Go to original source... Go to PubMed...
    8. Študent V, Fiala R. První výsledky studie Kapros v Olomouckém kraji. Čes Urol 2006; 1: 19-22.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.